Vulvar Skin Atrophy Induced by Topical Glucocorticoids

13Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Steroid-induced skin atrophy is the most frequent and perhaps most important cutaneous side effect of topical glucocorticoid therapy. To date, it has not been described in vulvar skin. A patient presented with significant vulvar skin atrophy following prolonged steroid application to treat vulvar dermatitis. The extensive atrophy in the perineum resulted in secondary "webbing" and partial obstruction of the genital hiatus and superimposed dyspareunia. Prolonged use of topical steroids may result in atrophic changes in vulvar skin. Further research in clinical correlates of steroid-induced atrophy in the vulvar region is warranted. © 2012 by the American College of Nurse-Midwives.

Cite

CITATION STYLE

APA

Johnson, E., Groben, P., Eanes, A., Iyer, P., Ugoeke, J., & Zolnoun, D. (2012). Vulvar Skin Atrophy Induced by Topical Glucocorticoids. Journal of Midwifery and Women’s Health, 57(3), 296–299. https://doi.org/10.1111/j.1542-2011.2012.00189.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free